Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests.
Magnolia Medical Technologies has raised $46.0M in total funding. The most recent round was Private Equity. The last funding was announced in February 2022.
Magnolia Medical Technologies's investors include Janus Henderson Investors, RTW Investments, HealthQuest Capital, Rhapsody Venture Partners, Horizon Technology Finance.
Magnolia Medical Technologies is headquartered in Seattle, United States.
Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests.
Magnolia Medical Technologies is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Magnolia Medical Technologies — Funding & Investors." VCBacked, February 16, 2022, https://www.vcbacked.co/company/magnolia-medical-technologies. Accessed September 29, 2026.
VCBacked. (2022). Magnolia Medical Technologies — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/magnolia-medical-technologies
{{cite web |title=Magnolia Medical Technologies — Funding & Investors |url=https://www.vcbacked.co/company/magnolia-medical-technologies |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated